SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells
PLOS Pathogens · 14.04.2023 · 19 (4) · e1011316
DOI: 10.1371/journal.ppat.1011316 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 14.04.2023. Verfasst von Le Wen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou, China. Hauptthemen laut MEDLINE: Glioma, Immediate-Early Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Institute of Pediatrics, Guangzhou Women and Childrens Medical Center.
Abstract (Originalsprache)
The presence of human cytomegalovirus (HCMV) in glioblastoma (GBM) and improved outcomes of GBM patients receiving therapies targeting the virus have implicated HCMV in GBM progression. However, a unifying mechanism that accounts for the contribution of HCMV to the malignant phenotype of GBM remains incompletely defined. Here we have identified SOX2, a marker of glioma stem cells (GSCs), as a key determinant of HCMV gene expression in gliomas. Our studies demonstrated that SOX2 downregulated promyelocytic leukemia (PML) and Sp100 and consequently facilitated viral gene expression by decreasing the amount of PML nuclear bodies in HCMV-infected glioma cells. Conversely, the expression of PML antagonized the effects of SOX2 on HCMV gene expression. Furthermore, this regulation of SOX2 on HCMV infection was demonstrated in a neurosphere assay of GSCs and in a murine xenograft model utilizing xenografts from patient-derived glioma tissue. In both cases, SOX2 overexpression facilitated the growth of neurospheres and xenografts implanted in immunodeficient mice. Lastly, the expression of SOX2 and HCMV immediate early 1 (IE1) protein could be correlated in tissues from glioma patients, and interestingly, elevated levels of SOX2 and IE1 were predictive of a worse clinical outcome. These studies argue that HCMV gene expression in gliomas is regulated by SOX2 through its regulation of PML expression and that targeting molecules in this SOX2-PML pathway could identify therapies for glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou, China.
- State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Wuhan Brain Hospital, Ministry of Transportation, Wuhan, China.
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
- Department of Medical Genetics, Oslo University Hospital/University of Oslo, Oslo, Norway.
ORCID-Profile: Min-Hua Luo
Förderung
- National Natural Science Foundation of China
- Guangzhou Institute of Pediatrics, Guangzhou Women and Childrens Medical Center
Zitieren
APA
Wen, L., Wang, X. Z., Qiu, Y., Zhou, Y. P., Zhang, Q. Y., Cheng, S., Sun, J. Y., Jiang, X. J., Rayner, S., Britt, W. J., Chen, J., Hu, F., Li, F. C., Luo, M. H., & Cheng, H. (2023). SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells. PLOS Pathogens, 19(4), e1011316. https://doi.org/10.1371/journal.ppat.1011316
Vancouver
Wen L, Wang XZ, Qiu Y, Zhou YP, Zhang QY, Cheng S, et al. SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells. PLOS Pathogens. 2023;19(4):e1011316. doi:10.1371/journal.ppat.1011316
BibTeX
@article{Wen2023,
author = {Wen, Le and Wang, Xian-Zhang and Qiu, Yong and Zhou, Yue-Peng and Zhang, Qing-Yang and Cheng, Shuang and Sun, Jin-Yan and Jiang, Xing-Jun and Rayner, Simon and Britt, William J and Chen, Jian and Hu, Fei and Li, Fang-Cheng and Luo, Min-Hua and Cheng, Han},
title = {SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {4},
pages = {e1011316},
doi = {10.1371/journal.ppat.1011316}
}
EUVIMED